サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1794739

副鼻腔炎治療薬の世界市場

Sinusitis Drugs

出版日
ページ情報
英文 276 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
副鼻腔炎治療薬の世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 276 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

副鼻腔炎治療薬の世界市場は2030年までに31億米ドルに到達

2024年に24億米ドルと推定される副鼻腔炎治療薬の世界市場は、分析期間2024-2030年にCAGR 3.8%で成長し、2030年には31億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるステロイド点鼻薬は、CAGR 3.0%を記録し、分析期間終了時には13億米ドルに達すると予測されます。抗生物質セグメントの成長率は、分析期間中CAGR 4.6%と推定されます。

米国市場は6億6,600万米ドルと推定、中国はCAGR6.9%で成長予測

米国の副鼻腔炎治療薬市場は、2024年に6億6,600万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.9%として、2030年までに6億1,150万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と2.9%と予測されています。欧州では、ドイツがCAGR 2.2%で成長すると予測されています。

世界の副鼻腔炎治療薬市場- 主要動向と促進要因まとめ

なぜ副鼻腔炎の治療介入はより専門化し、ターゲットを絞るようになったのか？

世界の副鼻腔炎治療薬市場は、副鼻腔炎の理解が進むにつれて、対症療法からメカニズムに特化したエンドタイプ主導の治療へとパラダイムシフトしつつあります。副鼻腔炎は急性（4週間以内）または慢性（12週間以上）に分類され、細菌性、ウイルス性、真菌性、アレルギー性などの要因によって引き起こされることが多く、それぞれ異なる薬理学的アプローチが必要とされます。しかし、慢性鼻副鼻腔炎（CRS）、特に鼻ポリープを伴う慢性鼻副鼻腔炎（CRSwNP）では、現在、根本的な2型炎症経路に対処する生物学的製剤や免疫調整薬が求められています。

このような精密治療へのニーズの高まりにより、治療標的としてのインターロイキン（IL-4、IL-5、IL-13）と免疫グロブリンE（IgE）への臨床的注目が高まっています。デュピルマブ（IL-4受容体α拮抗薬）などのモノクローナル抗体は規制当局の承認を得て、難治性CRSwNP患者の治療状況を変えつつあります。これらの薬剤は、ポリープの大きさや副鼻腔の閉塞を減少させるだけでなく、長期間の追跡調査によって嗅覚やQOLの指標も改善します。このような生物学的製剤は、副腎皮質ステロイドや手術と並んで、特に喘息合併患者に対する治療ガイドラインに組み込まれつつあります。副鼻腔炎の病態がより広範な呼吸器炎症症候群とますます関連するようになるにつれて、薬理学的な武器はより強固に、調整され、学際的になってきています。

市場力学はドラッグ製剤とデリバリーの革新にどのように影響されるか？

副鼻腔炎治療薬市場において、製剤とデリバリーシステムは極めて重要な役割を担っています。鼻腔スプレー、点鼻薬、ネブライザー製剤が第一線の送達プラットフォームとして主流を占めているが、副鼻腔に到達する能力は様々であり、特に重度の閉塞や解剖学的変異を有する患者ではその差が大きいです。これに対処するため、各社は呼気デリバリーシステム、呼気を動力とする双方向デバイス、植え込み型コルチコステロイド溶出ステントなどの先進デバイスを開発しています。これらの技術革新により、薬物が副鼻腔の奥深くまで確実に到達し、治療濃度が長期にわたって維持されます。

モメタゾンやブデソニドのようなコルチコステロイドの徐放性製剤は、全身的な副作用を抑えながら局所的な抗炎症効果を持続させることができます。同様に、抗ヒスタミン薬、抗コリン薬、ロイコトリエン受容体拮抗薬などを配合した製剤も、病因が混在する患者において複数の経路を標的とするために導入されつつあります。以前は皮下注射が必要であった生物学的製剤は、安定性や生物学的利用能に関する課題は残るもの、経鼻やより侵襲性の低いデリバリー経路の研究が進められています。こうした製剤の進歩は、特に治療サイクルの延長や維持レジメンを必要とする慢性症例において、処方者の選択肢を広げ、患者のアドヒアランスを向上させています。

さらに、抗生物質のスチュワードシップが薬剤開発戦略を形成しつつあります。耐性菌に対する懸念の高まりから、急性副鼻腔炎に対する経験的抗生物質の使用は抑制されつつあり、細菌感染を正確に特定するための迅速診断ツールの開発が推し進められています。広域スペクトルの経口療法に代わるものとして、狭域スペクトル抗生物質、局所抗菌薬、バイオフィルム破壊剤が研究されています。規制当局や臨床医が抗生物質の慎重な使用を優先する中、慢性副鼻腔炎の管理においては抗炎症薬、抗真菌薬、免疫治療薬に重点が移りつつあります。

どのような患者属性と併存疾患が需要のばらつきをもたらしているのか？

患者の層別化は、副鼻腔炎治療における市場セグメンテーションの要となりつつあります。鼻ポリープを伴う慢性副鼻腔炎は、喘息、アスピリン増悪性呼吸器疾患（AERD）、アレルギー性真菌性鼻副鼻腔炎を基礎疾患とする30～60歳の成人で診断されることが多くなっています。これらの患者群は、生物学的製剤による治療や長期療養の主な対象です。一方、小児の副鼻腔炎は、ウイルス性またはアレルギー性の誘因に関連することが多く、全身的な薬物曝露は少なく、短期間の副腎皮質ステロイドと鼻腔洗浄に頼っているのが現状です。アデノイド肥大や感染を繰り返す小児には、低用量で年齢に応じた処方の経口抗ヒスタミン薬、ロイコトリエン拮抗薬、抗生物質が用いられます。

老年患者、特にCOPDや心血管疾患を合併している患者では、ステロイド、抗ヒスタミン薬、充血除去薬による全身性の副作用を避けるため、慎重な薬剤選択が必要です。高齢者集団における副鼻腔炎の個別化治療の動向は、局所作用型で副作用を最小限に抑えた製剤への需要を押し上げています。大気汚染やアレルゲンへの暴露が多い都市部では慢性副鼻腔炎の発症率が高く、長期的な副鼻腔炎対策が求められています。特に北米や欧州のような副鼻腔炎罹患率が冬季にピークを迎える市場では、季節変動が製品の普及にさらに影響を及ぼします。

さらに、副鼻腔炎と睡眠障害、認知疲労、メンタルヘルスとの関連性に対する意識の高まりが、ホリスティックケアへのアプローチを促しています。このため、副鼻腔炎治療薬を併存疾患管理レジメンにバンドルする動きが活発化しており、医薬品メーカーにとっては治療薬横断的な市場機会が拡大しています。遠隔医療の導入により副鼻腔炎の診察へのアクセスが拡大し、遠隔地や半都市部の市場において、デジタル調剤された鼻用副腎皮質ステロイド薬やコンビネーションスプレーの処方量が増加しています。

副鼻腔炎治療薬のエコシステムを形成する主要な成長加速要因は何か？

世界の副鼻腔炎治療薬市場の成長は、治療手段の拡大、診断プロトコルの進化、副鼻腔の健康に対する患者の関与の増加を強調するいくつかの要因によって牽引されています。特に、喘息やアトピー性皮膚炎の治療薬として承認され、現在ではCRSwNPにもクロスインディケーションされている生物学的製剤が、重症慢性副鼻腔炎の治療薬として登場し、償還されるようになったことが、最も大きな要因です。これらの薬剤は割高な価格設定であるが、長期的な臨床的寛解をもたらし、外科的介入や入院を減らすことができます。耳鼻咽喉科と呼吸器科の融合は、治療経路の共有と協調ケアモデルを促進し、二重処方の普及を促しています。

高負担国における政府主導の医療プログラムや保険制度改革は、ジェネリック医薬品と専門薬の両方への患者アクセスを拡大しています。耳鼻咽喉科に特化した遠隔医療サービスやe-pharmacyプラットフォームの台頭は、服薬アドヒアランスと再処方率を向上させています。デジタル副鼻腔画像やバイオマーカー診断への投資により、標的薬剤の患者選択が強化され、試行錯誤の処方が減少しています。製薬会社は共同マーケティング契約を結び、抗ヒスタミン薬、充血除去薬、生物学的製剤を統一した治療ブランドで販売し、包括的な治療ポートフォリオを構築しています。

最後に、患者中心のマーケティング、健康啓発キャンペーン、副鼻腔の健康状態をモニタリングするモバイルアプリの普及により、疾患に対するリテラシーが向上し、早期介入が促されています。こうした新興国市場の開発は、ドラッグデリバリー、マイクロバイオーム標的治療薬、抗炎症ペプチドなどにおける継続的な技術革新と相まって、副鼻腔炎治療薬市場を急性期から慢性期まで幅広く堅調に拡大させています。

セグメント

製品タイプ（ステロイド点鼻薬、抗生物質、充血除去薬、その他製品）、疾患タイプ（急性副鼻腔炎、慢性副鼻腔炎、亜急性副鼻腔炎）

調査対象企業の例

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bionorica SE
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • Dr.Reddy's Laboratories Ltd.
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mylan（Viatris）
  • Neopharma Corp.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teligent Inc.
  • Teva Pharmaceutical Industries Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38019

Global Sinusitis Drugs Market to Reach US$3.1 Billion by 2030

The global market for Sinusitis Drugs estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Steroid Nasal Sprays, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Antibiotics segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$666.0 Million While China is Forecast to Grow at 6.9% CAGR

The Sinusitis Drugs market in the U.S. is estimated at US$666.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$611.5 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Sinusitis Drugs Market - Key Trends & Drivers Summarized

Why Are Therapeutic Interventions for Sinusitis Becoming More Specialized and Targeted?

The global sinusitis drugs market is undergoing a paradigm shift from symptom-oriented treatment to mechanism-specific, endotype-driven therapy, as the understanding of sinus inflammation evolves. Sinusitis-classified as acute (lasting up to 4 weeks) or chronic (lasting 12 weeks or longer)-is often triggered by bacterial, viral, fungal, or allergic factors, each requiring a distinct pharmacological approach. Traditional therapies such as decongestants, mucolytics, and corticosteroid sprays remain staples for acute cases, but chronic rhinosinusitis (CRS), particularly with nasal polyps (CRSwNP), now demands biologics and immune-modulating drugs that address the underlying type 2 inflammation pathways.

This growing need for precision therapy has intensified clinical focus on interleukins (IL-4, IL-5, IL-13) and Immunoglobulin E (IgE) as therapeutic targets. Monoclonal antibodies such as dupilumab (IL-4 receptor alpha antagonist) have gained regulatory approval and are altering the treatment landscape for patients with refractory CRSwNP. These drugs not only reduce polyp size and sinus obstruction but also improve olfaction and quality of life metrics over long-term follow-up. Such biologics are being integrated into treatment guidelines alongside corticosteroids and surgery, especially for patients with asthma comorbidities. As sinusitis pathology becomes increasingly associated with broader respiratory inflammatory syndromes, the pharmacologic armamentarium is becoming more robust, tailored, and interdisciplinary.

How Are Market Dynamics Influenced by Drug Formulations and Delivery Innovation?

Formulation and delivery systems play a pivotal role in the sinusitis drug market, where achieving localized, long-duration drug deposition in the sinuses remains challenging. Nasal sprays, irrigations, and nebulized formulations dominate front-line delivery platforms, but they vary widely in their ability to reach the sinus cavities, especially in patients with severe obstruction or anatomical variations. To address this, companies are developing advanced devices such as exhalation delivery systems, breath-powered bidirectional devices, and implantable corticosteroid-eluting stents. These innovations ensure drug reaches deep into the sinuses and maintains therapeutic concentrations over time.

Extended-release formulations of corticosteroids such as mometasone and budesonide are enabling sustained local anti-inflammatory effects with fewer systemic side effects. Similarly, combination formulations incorporating antihistamines, anticholinergics, or leukotriene receptor antagonists are being introduced to target multiple pathways in patients with mixed etiologies. Biologic drugs, which previously required subcutaneous injections, are being studied for intranasal or less invasive delivery routes, although challenges remain regarding stability and bioavailability. These formulation advancements are expanding prescriber options and patient adherence, particularly in chronic cases that require prolonged treatment cycles or maintenance regimens.

Moreover, antibiotic stewardship is shaping drug development strategies. Due to rising concerns about resistance, empiric antibiotic use for acute sinusitis is being curtailed, pushing the development of rapid diagnostic tools to identify bacterial infections precisely. Narrow-spectrum antibiotics, topical antibacterials, and biofilm-disrupting agents are being researched to replace broad-spectrum oral therapies. As regulators and clinicians prioritize judicious antibiotic use, the emphasis is shifting toward anti-inflammatory, anti-fungal, and immunotherapeutic drugs in chronic sinusitis management.

Which Patient Demographics and Comorbidities Are Driving Demand Variability?

Patient stratification is becoming a cornerstone of market segmentation in sinusitis treatment. Chronic sinusitis with nasal polyps is increasingly diagnosed in adults aged 30-60 with underlying asthma, aspirin-exacerbated respiratory disease (AERD), or allergic fungal rhinosinusitis. These patient groups represent the primary candidates for biologic therapies and extended-care management. Meanwhile, pediatric sinusitis, often linked to viral or allergic triggers, continues to rely on short-term corticosteroids and nasal irrigation, with low systemic drug exposure. Children with adenoid hypertrophy or recurrent infections may be treated with lower-dose, age-appropriate formulations of oral antihistamines, leukotriene antagonists, or antibiotics.

Geriatric patients, especially those with co-existing COPD or cardiovascular diseases, require cautious drug selection to avoid systemic side effects of steroids, antihistamines, or decongestants. The trend toward personalized sinusitis care in older populations is pushing demand for locally acting, side-effect-minimized formulations. Geographic and environmental factors also influence market dynamics-urban regions with high air pollution and allergen exposure see higher chronic sinusitis incidence, prompting a demand for long-term control strategies. Seasonal variations further affect product uptake, especially in markets like North America and Europe, where sinusitis incidence peaks during winter months.

Additionally, increasing awareness about the link between sinusitis and sleep disorders, cognitive fatigue, and mental health is prompting holistic care approaches. This is leading to the bundling of sinusitis drugs with comorbidity management regimens, enhancing cross-therapeutic market opportunities for drug makers. Telemedicine adoption has expanded access to sinusitis consultations, increasing prescription volumes of digitally dispensed nasal corticosteroids and combination sprays across remote and semi-urban markets.

What Are the Primary Growth Accelerators Reshaping the Sinusitis Drug Ecosystem?

The growth in the global sinusitis drugs market is driven by several factors that highlight the expanding treatment arsenal, evolving diagnostic protocols, and increasing patient engagement in sinus health. The most significant catalyst is the emergence and reimbursement of biologic therapies for severe chronic sinusitis, especially those approved for asthma or atopic dermatitis and now cross-indicated for CRSwNP. These drugs command premium pricing but offer long-term clinical remission, reducing surgical interventions and hospitalizations. The convergence of ENT and respiratory medicine is facilitating shared treatment pathways and coordinated care models, encouraging dual-prescription uptake.

Government-sponsored health programs and insurance reforms in high-burden countries are expanding patient access to both generics and specialty drugs. The rise of ENT-specialized telehealth services and e-pharmacy platforms is improving adherence and refilling rates. Investment in digital sinus imaging and biomarker diagnostics is enhancing patient selection for targeted drugs, reducing trial-and-error prescriptions. Pharmaceutical companies are forming co-marketing agreements to bundle antihistamines, decongestants, and biologics under unified treatment brands, creating comprehensive care portfolios.

Lastly, patient-centric marketing, health awareness campaigns, and the proliferation of mobile apps for sinus health monitoring are increasing disease literacy and encouraging early intervention. These developments, combined with ongoing innovation in drug delivery, microbiome-targeted therapies, and anti-inflammatory peptides, are positioning the sinusitis drug market for robust expansion across acute and chronic care spectrums.

SCOPE OF STUDY:

The report analyzes the Sinusitis Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Steroid Nasal Sprays, Antibiotics, Decongestants, Other Products); Disease Type (Acute Sinusitis, Chronic Sinusitis, Sub-acute Sinusitis)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bionorica SE
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • Dr.?Reddy's Laboratories Ltd.
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mylan (Viatris)
  • Neopharma Corp.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teligent Inc.
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Sinusitis Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic and Recurrent Sinusitis Conditions Drives Long-Term Demand
    • Expanding Use of Combination Drug Therapies Throws Spotlight on Fixed-Dose Innovations
    • Growth in Over-the-Counter Allergy Medications Supports Non-Prescription Sinus Relief
    • Increased Use of Nasal Corticosteroids Enhances Treatment Adherence and Outcomes
    • Technological Advancements in Drug Delivery Devices Improve Efficacy and Patient Compliance
    • OEM Integration With ENT Specialists and Clinics Drives Prescription Volume
    • Surge in Demand for Drug-Free and Natural Remedies Expands Product Portfolios
    • Expansion of E-Pharmacy Channels Improves Access to Nasal and Oral Sinus Medications
    • Rising Emphasis on Precision Medicine Strengthens Interest in Genotype-Specific Therapies
    • Global Burden of Air Pollution and Allergens Fuels Sinusitis Medication Demand
    • Product Launches Featuring Dual-Action Antihistamine-Decongestant Formulations Propel Growth
    • Increased Healthcare Spending in Emerging Economies Promotes Adoption of Branded Drugs
    • Shift Toward Minimally Invasive Sinus Procedures Boosts Post-Operative Drug Demand
    • R&D in Biologic and Targeted Therapies Opens New Avenues for Severe Sinusitis Management
    • Proliferation of Telemedicine Platforms Enhances Remote Diagnosis and Prescription Fulfillment
    • Patent Expiry of Major Brands Generates Opportunities for Generic Drug Penetration
    • Emphasis on Pediatric and Geriatric Sinus Care Expands Dosing Innovations
    • Regional Allergy Trends Influence Seasonal Demand and Inventory Planning
    • Expansion of Hospital-Based ENT Clinics in Urban Areas Strengthens Institutional Procurement
    • Clinical Guidelines on Sinusitis Management Support Evidence-Based Drug Prescriptions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sinusitis Drugs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sinusitis Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sinusitis Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sinusitis Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Steroid Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Steroid Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Steroid Nasal Sprays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Decongestants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Decongestants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Decongestants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Acute Sinusitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Acute Sinusitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Acute Sinusitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Chronic Sinusitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Chronic Sinusitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Chronic Sinusitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Sub-acute Sinusitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Sub-acute Sinusitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Sub-acute Sinusitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • JAPAN
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • CHINA
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • EUROPE
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Sinusitis Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Sinusitis Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Sinusitis Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • FRANCE
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • GERMANY
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Sinusitis Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Sinusitis Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Sinusitis Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • INDIA
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Sinusitis Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Sinusitis Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Sinusitis Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Sinusitis Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Sinusitis Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Sinusitis Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030
  • AFRICA
    • Sinusitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Sinusitis Drugs by Product - Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Sinusitis Drugs by Product - Percentage Breakdown of Value Sales for Steroid Nasal Sprays, Antibiotics, Decongestants and Other Products for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Sinusitis Drugs by Disease Type - Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Sinusitis Drugs by Disease Type - Percentage Breakdown of Value Sales for Acute Sinusitis, Chronic Sinusitis and Sub-acute Sinusitis for the Years 2014, 2025 & 2030

IV. COMPETITION